Compare WST & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | EL |
|---|---|---|
| Founded | 1923 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9B | 40.5B |
| IPO Year | 2004 | 2007 |
| Metric | WST | EL |
|---|---|---|
| Price | $413.19 | $104.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 30 |
| Target Price | ★ $471.00 | $116.49 |
| AVG Volume (30 Days) | 684.4K | ★ 3.4M |
| Earning Date | 10-29-2026 | 11-02-2026 |
| Dividend Yield | 0.25% | ★ 1.29% |
| EPS Growth | 1.49 | ★ 115.87 |
| EPS | ★ 7.09 | 0.64 |
| Revenue | $2,886,900,000.00 | ★ $15,049,000,000.00 |
| Revenue This Year | $11.26 | $5.51 |
| Revenue Next Year | $5.92 | $4.38 |
| P/E Ratio | ★ $58.97 | $169.70 |
| Revenue Growth | 1.95 | ★ 5.05 |
| 52 Week Low | $223.83 | $66.22 |
| 52 Week High | $438.27 | $121.64 |
| Indicator | WST | EL |
|---|---|---|
| Relative Strength Index (RSI) | 61.20 | 45.61 |
| Support Level | $386.88 | $103.09 |
| Resistance Level | $438.27 | $108.38 |
| Average True Range (ATR) | 11.71 | 4.70 |
| MACD | -0.32 | -0.75 |
| Stochastic Oscillator | 50.40 | 10.26 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Since its founding in 1946, Estée Lauder has become a leading global manufacturer and marketer of prestige skincare (nearly half of sales), makeup (28%), fragrance (19%), and haircare products (4%). Beyond its namesake brand, the firm's portfolio of offerings includes Clinique, M.A.C., La Mer, Jo Malone London, and Tom Ford, among others. The US and China each account for about one-quarter of its consolidated sales. The firm sells its products through physical and e-commerce platforms at company-owned outlets alongside department stores, specialty retailers, and salons globally.